Mithraprabhu S - Search Results

1

Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma.

Mithraprabhu S, Khong T, Ramachandran M, Chow A, Klarica D, Mai L, Walsh S, Broemeling D, Marziali A, Wiggin M, Hocking J, Kalff A, Durie B, Spencer A. Mithraprabhu S, et al. Leukemia. 2017 Aug;31(8):1695-1705. doi: 10.1038/leu.2016.366. Epub 2016 Nov 30. Leukemia. 2017. PMID: 27899805

2

Deactylase inhibition in myeloproliferative neoplasms.

Mithraprabhu S, Grigoriadis G, Khong T, Spencer A. Mithraprabhu S, et al. Invest New Drugs. 2010 Dec;28 Suppl 1(Suppl 1):S50-7. doi: 10.1007/s10637-010-9590-4. Epub 2010 Dec 3. Invest New Drugs. 2010. PMID: 21127942 Free PMC article. Review.

3

Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC.

Mithraprabhu S, Khong T, Jones SS, Spencer A. Mithraprabhu S, et al. Br J Haematol. 2013 Aug;162(4):559-62. doi: 10.1111/bjh.12388. Epub 2013 May 21. Br J Haematol. 2013. PMID: 23692150 Free article. No abstract available.

4

Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome.

Tan P, Wei A, Mithraprabhu S, Cummings N, Liu HB, Perugini M, Reed K, Avery S, Patil S, Walker P, Mollee P, Grigg A, D'Andrea R, Dear A, Spencer A. Tan P, et al. Among authors: mithraprabhu s. Blood Cancer J. 2014 Jan 10;4(1):e170. doi: 10.1038/bcj.2013.68. Blood Cancer J. 2014. PMID: 24413064 Free PMC article.

5

Overcoming inherent resistance to histone deacetylase inhibitors in multiple myeloma cells by targeting pathways integral to the actin cytoskeleton.

Mithraprabhu S, Khong T, Spencer A. Mithraprabhu S, et al. Cell Death Dis. 2014 Mar 20;5(3):e1134. doi: 10.1038/cddis.2014.98. Cell Death Dis. 2014. PMID: 24651437 Free PMC article.

6

A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia.

Kalff A, Khong T, Wall M, Gorniak M, Mithraprabhu S, Campbell LJ, Spencer A. Kalff A, et al. Among authors: mithraprabhu s. Haematologica. 2015 Feb;100(2):e60-2. doi: 10.3324/haematol.2014.111385. Epub 2014 Nov 7. Haematologica. 2015. PMID: 25381133 Free PMC article. No abstract available.

7

Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.

Mithraprabhu S, Kalff A, Chow A, Khong T, Spencer A. Mithraprabhu S, et al. Epigenetics. 2014 Nov;9(11):1511-20. doi: 10.4161/15592294.2014.983367. Epigenetics. 2014. PMID: 25482492 Free PMC article.

8

Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies.

Hocking J, Mithraprabhu S, Kalff A, Spencer A. Hocking J, et al. Among authors: mithraprabhu s. Cancer Biol Med. 2016 Jun;13(2):215-25. doi: 10.20892/j.issn.2095-3941.2016.0025. Cancer Biol Med. 2016. PMID: 27458529 Free PMC article.

9

Circulating tumour DNA analysis in multiple myeloma.

Mithraprabhu S, Spencer A. Mithraprabhu S, et al. Oncotarget. 2017 Oct 7;8(53):90610-90611. doi: 10.18632/oncotarget.21595. eCollection 2017 Oct 31. Oncotarget. 2017. PMID: 29207579 Free PMC article. No abstract available.

10

Analysis of Circulating Tumor DNA.

Mithraprabhu S, Spencer A. Mithraprabhu S, et al. Methods Mol Biol. 2018;1792:129-145. doi: 10.1007/978-1-4939-7865-6_9. Methods Mol Biol. 2018. PMID: 29797256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters